| Lung Non-Small Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 313show all (up to 200) |
|---|
| → investigated in trials for | Carboplatinsmall molecule 557 trials (196 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 557 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall_molecule 493 trials (166 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 493 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 417 trials (196 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 417 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 378 trials (121 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 378 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall_molecule 327 trials (93 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 327 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall_molecule 318 trials (76 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 318 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall_molecule 197 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 197 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal_antibody 192 trials (71 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 192 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 183 trials (32 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 183 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall_molecule 182 trials (35 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 182 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall_molecule 160 trials (88 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 160 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 148 trials (55 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 148 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 112 trials (33 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 112 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall_molecule 98 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 98 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 95 trials (43 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 95 | Observed | clinicaltrials | graph → |